FDA adds generic valganciclovir oral solution - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA adds generic valganciclovir oral solution

 The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.

  • By

  • Mouj Hijazi

  • October 28, 2026

  • 2 min

Share

Original Source(s)

FDA adds generic valganciclovir oral solution

  • by Mouj Hijazi

  • October 28, 2026

Related Content

Cryptococcal cellulitis may lead to amputation

A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.

FDA expands treatment in nephrotic syndrome

The indication marks an additional use for a therapy previously approved for certain cancers and active lupus nephritis.

OM-89 may curb postantibiotic E coli regrowth

Lysosomal activation and increased intracellular antibiotic accumulation accompanied reduced bacterial regrowth across mouse and human bladder epithelial models.